1. S129 Does inflammation predict successful pleurodesis? a post hoc analysis from the time 1 trial. (15th November 2017) Authors: Mercer, RM; Macready, J; Jeffries, H; Speck, N; Kanellakis, N; Maskell, N; Pepperell, J; Saba, T; Ali, N; West, A; Miller, RF; Asciak, R; Hallifax, R; Corcoran, JC; Hassan, M; Psallidas, I; Rahman, NM Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S132 Survival and pleurodesis outcome in patients with malignant pleural effusion – post-hoc analysis from the TIME-1 trial. (December 2018) Authors: Hassan, M; Mercer, RM; Maskell, N; Pepperell, J; Saba, T; Ali, N; West, A; Miller, RF; Hallifax, RJ; Corcoran, JP; Asciak, R; McCracken, D; Bedawi, EO; Rahman, NM Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S20 Primary Result of the 1st Therapeutic Interventions in Malignant Effusion (TIME1) Trial: A 2 × 2 factorial, randomised trial of chest tube size and analgesic strategy for pleurodesis in malignant pleural effusion. (12th November 2015) Authors: Rahman, NM; Pepperell, J; Rehal, S; Saba, T; Tang, A; Ali, N; West, A; Hettiarachchi, G; Mukherjee, D; Samuel, J; Bentley, A; Dowson, L; Miles, J; Ryan, F; Yoneda, K; Chauhan, A; Corcoran, J; Psallidas, I; Wrightson, JM; Hallifax, R Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗